Highlighted Holding – Fresenius Medical Care

Recording Date: November 11, 2021

The impact of COVID-19 on Fresenius Medical Care is inherently transient. At the same time, favorable industry trends are emerging, the benefits of which should largely accrue to the world’s preeminent dialysis company. Senior Research Analyst Eric Hagemann and Portfolio Manager John Flynn discuss Pzena’s recent investment in Fresenius Medical Care on the latest episode of the PzenaPerspectives podcast.

Website Posts
Website Posts
Highlighted Holding - Fresenius Medical Care
/